Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes

被引:3
作者
Larsson, Helena Elding [1 ]
Jonsson, Ida [1 ]
Lernmark, Ake [1 ]
Ivarsson, Sten [2 ]
Radtke, Jared R. [3 ]
Hampe, Christiane S. [3 ]
机构
[1] Lund Univ, Dept Clin Sci, Malmo, Sweden
[2] Univ Hosp MAS, Dept Pediat, Malmo, Sweden
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
SYSTEMIC LUPUS-ERYTHEMATOSUS; DECARBOXYLASE; IMMUNIZATION; POPULATION; NETWORK; AGE;
D O I
10.1371/journal.pone.0065173
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The humoral Idiotypic Network consisting of antibodies and their anti-idiotypic antibodies (anti-Id) can be temporarily upset by antigen exposure. In the healthy immune response the original equilibrium is eventually restored through counter-regulatory mechanisms. In certain autoimmune diseases however, autoantibody levels exceed those of their respective anti-Id, indicating a permanent disturbance in the respective humoral Idiotypic Network. We investigated anti-Id directed to a major Type 1 diabetes (T1D)-associated autoantibody (GAD65Ab) in two independent cohorts during progression to disease. Samples taken from participants of the Natural History Study showed significantly lower anti-Id levels in individuals that later progressed to T1D compared to non-progressors (anti-Id antibody index of 0.06 vs. 0.08, respectively, p = 0.02). We also observed a significant inverse correlation between anti-Id levels and age at sampling, but only in progressors (p = 0.014). Finally, anti-Id levels in progressors showed a significant decline during progression as compared to longitudinal anti-Id levels in non-progressors (median rate of change: -0.0004 vs. +0.0004, respectively, p = 0.003), suggesting a loss of anti-Id during progression. Our analysis of the Diabetes Prediction in Skane cohort showed that early in life (age 2) individuals at risk have anti-Id levels indistinguishable from those in healthy controls, indicating that low anti-Id levels are not an innate characteristic of the immune response in individuals at risk. Notably, anti-Id levels declined significantly in individuals that later developed GAD65Ab suggesting that the decline in anti-Id levels precedes the emergence of GAD65Ab (median rate of change: -0.005) compared to matched controls (median rate of change: +0.001) (p = 0.0016). We conclude that while anti-Id are present early in life, their levels decrease prior to the appearance of GAD65Ab and to the development of T1D.
引用
收藏
页数:7
相关论文
共 27 条
[1]   Extended Family History of Diabetes and Autoimmune Diseases in Children With and Without Type 1 Diabetes [J].
Alhonen, Salla ;
Korhonen, Sari ;
Tapanainen, Paivi ;
Knip, Mikael ;
Veijola, Riitta .
DIABETES CARE, 2011, 34 (01) :115-117
[2]   RADIOIMMUNOASSAYS FOR GLUTAMIC-ACID DECARBOXYLASE (GAD65) AND GAD65 AUTOANTIBODIES USING S-35 OR H-3 RECOMBINANT HUMAN LIGANDS [J].
FALORNI, A ;
ORTQVIST, E ;
PERSSON, B ;
LERNMARK, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 186 (01) :89-99
[3]  
GEHA RS, 1985, RES CLIN LAB, V15, P1
[4]  
GEHA RS, 1983, J IMMUNOL, V130, P1634
[5]   A NOVEL RADIOLIGAND BINDING ASSAY TO DETERMINE DIAGNOSTIC-ACCURACY OF ISOFORM-SPECIFIC GLUTAMIC-ACID DECARBOXYLASE ANTIBODIES IN CHILDHOOD IDDM [J].
GRUBIN, CE ;
DANIELS, T ;
TOIVOLA, B ;
LANDINOLSSON, M ;
HAGOPIAN, WA ;
LI, L ;
KARLSEN, AE ;
BOEL, E ;
MICHELSEN, B ;
LERNMARK, A .
DIABETOLOGIA, 1994, 37 (04) :344-350
[6]  
Hampe CS, 2012, AUTOIMMUNITY
[7]   Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients [J].
Harjutsalo, V ;
Podar, T ;
Tuomilehto, J .
DIABETES, 2005, 54 (02) :563-569
[8]   Immunogenicity of engineered antibodies [J].
Hwang, WYK ;
Foote, J .
METHODS, 2005, 36 (01) :3-10
[9]  
JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373
[10]   Diabetes-associated HLA genotypes affect birthweight in the general population [J].
Larsson, HE ;
Lynch, K ;
Lernmark, B ;
Nilsson, A ;
Hansson, G ;
Almgren, P ;
Lernmark, Å ;
Ivarsson, SA .
DIABETOLOGIA, 2005, 48 (08) :1484-1491